Chapter 277 is hard to talk about.
Chapter 277 is hard to talk about.
……
It's no wonder he's so happy.
Because it is a specific drug that can conquer pancreatic cancer, it is definitely a world first and the first drug to do so.
Pancreatic cancer is known as the king of cancers.
The reason for this title,
It’s not because of the large number of people who are sick.
But it is because this disease is difficult to cure.
Even many early-stage patients cannot survive.
Not to mention patients in the middle and late stages.
Pancreatic cancer is a topic of great concern to the whole world.
"A special medicine for pancreatic cancer?" Luo Shiyun was completely shocked.
Because she knew very well how terrible pancreatic cancer was and how huge the market was.
"Wait, you said the first new drug is a pancreatic cancer drug."
"So you mean you have new medicine besides this special medicine?"
Luo Shiyun suddenly realized this and her face was filled with disbelief.
She was so shocked by the magic and market of the pancreatic cancer drug that she ignored the other information in the words.
Now that I realized it, I realized that the medicine Chen Xuan mentioned was probably more than one kind, and even the special medicine for pancreatic cancer was just one of them.
If it wasn't a slip of the tongue, then he must have other new drugs.
The probability of this slip of the tongue is very small because he has said similar things more than once.
It is possible to make a slip of the tongue once, but it is impossible to make such a mistake so many times in a row. It is very likely that there are other new drugs.
Moreover, this new drug has also reached the clinical trial stage.
If this is true, then this news is too incredible and too shocking.
"Yes, I do have other new drugs." Chen Xuan nodded bluntly and admitted it.
The third stage of the system did bring him a big surprise.
Because the two previously activated stages only rewarded a special medicine formula for treating cancer.
But after the activation of this third stage, it not only rewards a special medicine formula for treating cancer, but also rewards another formula.
This recipe was an unexpected surprise that even surprised him.
After all, Chen Xuan had always expected to obtain a drug formula, but he didn't expect that a new drug would appear this time.
This unexpected bonus is indeed the biggest surprise.
"So what's this new drug?"
"Is this also a drug that can cure cancer?" Luo Shiyun asked expectantly.
The fact that we can develop a specific drug for cancer is already the biggest surprise.
But she didn't expect that Chen Xuan had other surprises.
"no,"
"This new drug is not for cancer, it is..." Chen Xuan shook his head, but he was reluctant to name the second new drug.
His expression even became a little awkward, simply because the characteristics of this new drug made it more or less difficult for him to speak.
It’s not that the new medicine is ineffective, but that the effect is so strong that he can’t even put it into words.
There is a sense of embarrassment of being forced to pretend to be cool.
"what?"
"What disease does it treat?"
Luo Shiyun asked again, feeling a little disappointed.
I thought it was a special medicine for cancer, but it turned out not to be.
However, looking at Chen Xuan's embarrassed expression, she suddenly felt a little confused.
This is not like his character. Why is he hesitating?
Isn’t he in the advanced stage of rectal cancer and he just says whatever he wants?
Could it be that this medicine is so special that he cannot easily disclose it to the outside world and needs to be kept secret for the time being?
But this drug is already undergoing clinical trials and must be announced to the public. It's impossible for her, the CEO, to not know about it, right?
The whole world knows, but she doesn't?
For a moment, the more Luo Shiyun thought about it, the weirder it seemed.
Then she suddenly thought of something and her face turned red for no reason.
Just at this moment, Chen Xuan spoke again.
"This new drug is mainly used to attack the human immunodeficiency virus."
"It can cause targeted elimination of human immunodeficiency virus and restore normal cells."
"It can also play a preventive role. After taking it, it can resist the invasion of the virus for a certain period of time and form antibodies, but there are currently obvious adverse reactions."
Chen Xuan quickly stated the characteristics of this drug.
Just pretend to be cool, anyway... he is always pretending to be cool.
"Human immunodeficiency virus?" Luo Shiyun repeated, the doubt in her eyes growing deeper and deeper.
It seemed like she was hearing this unfamiliar name for the first time.
What kind of disease is this?
And why didn’t Chen Xuan use the abbreviation, but instead used such a professional academic name?
But soon, she reacted.
"and many more?"
"You're not referring to HIV when you say human immunodeficiency virus, are you?"
Luo Shiyun suddenly shouted.
We often hear about HIV, but forget that its full name is human immunodeficiency virus.
HIV is also known as human immunodeficiency virus and is the main cause of acquired immunodeficiency syndrome.
Acquired immunodeficiency syndrome, commonly known as AIDS, is divided into different types.
HIV is no longer a terminal illness. There are many treatments that can delay the progression of the disease, but it is almost impossible to cure it.
All treatment plans are aimed at controlling the patient's condition and prolonging the patient's survival time as much as possible, which means that the medicine needs to be taken for life.
Moreover, this disease will destroy the body's normal immune system, making the patient's body increasingly fragile.
Ordinary people may be able to easily get over minor illnesses and pains, but AIDS patients are very likely to not make it. Once the immune system is damaged, even a small virus can cause fatal damage.
Most importantly, resistance to many drugs exists.
For diseases like AIDS that require lifelong medication, drug resistance will become increasingly obvious.
Every once in a while, you need to change the treatment plan or the medicine to continue to control the disease. Otherwise, it is very likely that the disease will worsen due to drug resistance.
Moreover, most treatment options have significant adverse reactions.
In addition, there are blocking drugs for AIDS, but the side effects are equally obvious. However, in high-risk situations, blocking drugs are also very necessary.
No matter how obvious the side effects are, it is better than getting yourself infected with AIDS.
Regarding what Luo Shiyun said about HIV.
Chen Xuan also nodded in affirmation.
Because the medicine he got can indeed treat HIV. It can block HIV and also treat HIV.
It's just that this medicine is a little special and has some side effects that he is embarrassed to say out loud.
"If it's a drug to treat HIV."
"I think this market is still very large. According to incomplete statistics from last year, there are approximately 5000 million people living with HIV worldwide."
“If you develop a new drug that’s better than current HIV treatment options, I think the market is going to be huge.”
After hearing that it was a drug to treat HIV,
Luo Shiyun also quickly conducted a market analysis and believed that this was a drug with great potential.
At the same time, she did not think there was anything difficult to talk about this drug, and she only thought about how big a market this drug could bring.
"Of course, this assumes the medicine is effective."
"If there are no other treatment options that are as good as the other treatment options, then there is no clear comparison."
"As such, even if we promote this drug now and successfully launch it on the market, the sales volume is estimated to be not very large."
Luo Shiyun then expressed her concerns.
This market is indeed very large. There are too many patients with this disease, and the number of infected people is increasing every year.
With such a large patient base alone, it is possible to generate sales of 500 small targets in a year, which is not impossible.
However, the premise of this best-selling drug is based on its efficacy. Only when the therapeutic effect exceeds other treatment options, and not just by 1 or 2 points, but with a very obvious gap, will there be a chance to achieve this goal.
After all, HIV is no longer a terminal illness and there are many treatment options.
If a new drug has no advantages in treatment, it will be difficult to compete with other drugs.
Other drugs already have a mature market, and neither pharmacies nor hospitals will rashly choose a new drug unless the new drug has extremely obvious therapeutic effects.
Therefore, therapeutic effect is the prerequisite. If there is no advantage, the performance of this new drug after it is launched on the market will probably be mediocre and will not cause any waves.
A drug without advantages does not even have the point of being launched on the market, because it is very likely that even the initial investment cannot be recovered.
……
20demayo